Black Health
Inhaled corticosteroid + long-acting beta-2 agonist (ICS + LABA) Asthma COPD

Fluticasone/Salmeterol (Advair Diskus, Advair HFA, Wixela, AirDuo) and Black patients

Brand names: Advair Diskus, Advair HFA, Wixela, AirDuo

Last reviewed: Sources checked:

What Fluticasone/Salmeterol does

Advair combines fluticasone (an inhaled corticosteroid) with salmeterol (a long-acting beta-2 agonist). The ICS suppresses airway inflammation while the LABA provides sustained bronchodilation. It is used twice daily as a controller for persistent asthma and COPD — not as a rescue inhaler.

What the evidence says for Black patients

Advair's Black-patient evidence base is mixed and politically fraught:

  • SMART trial (Nelson et al., Chest 2006;129:15–26, PMID 16424409) raised concerns that salmeterol alone increased asthma-related deaths, with the signal particularly concerning in Black participants. This led to the 2010 FDA requirement that LABAs be used only in combination with ICS in asthma, never alone. For combination ICS+LABA products like Advair, large subsequent trials (AUSTRI, 2016) showed reassuring safety when the ICS is present.
  • The BARD trial in children (Wechsler et al., NEJM 2019;381:1227–39, PMID 31553835) found Black children with uncontrolled asthma responded better to doubling the ICS dose than to adding a LABA — the opposite of the adult NAEPP pathway. This suggests race-specific step-up strategies may be warranted in Black pediatric asthma.
  • In adults, ICS+LABA remains standard; Black patients with moderate-severe asthma benefit from combination therapy when ICS monotherapy is inadequate.
  • Access. Advair has generic equivalents (Wixela, AirDuo) that substantially reduced cost. Use of these should be advocated for Black patients navigating insurance step therapy.

Common alternatives

Budesonide/formoterol (Symbicort) — notable because formoterol has fast onset, allowing SMART (single maintenance and reliever therapy). Mometasone/formoterol (Dulera). Fluticasone furoate/vilanterol (Breo) — once-daily. For children of any race with moderate asthma, consider doubling the ICS before adding a LABA per BARD.

Side effects

  • Oral candidiasis (thrush) — rinse mouth after use
  • Hoarseness (ICS-related)
  • Pneumonia in COPD
  • Tremor, tachycardia (LABA)
  • Systemic steroid effects at high doses: adrenal suppression, bone loss
  • Growth suppression in children (modest, reversible)

Factors that affect adherence

Daily use is required even when you feel well — this is the single most common missed teaching point. Generic Wixela or AirDuo is substantially cheaper than brand Advair.

Questions to ask your doctor

Bring this list to your next appointment.

  • If I have a Black child with asthma, should we double the ICS first before adding a LABA?
  • Am I using this every day as a controller, not as rescue?
  • Does my plan cover generic Wixela?
  • Can you watch my inhaler technique?

References

  1. Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial (SMART). Chest. 2006;129:15–26. PMID 16424409.
  2. Wechsler ME, Szefler SJ, Ortega VE, et al. Step-up therapy in black children and adults with poorly controlled asthma (BARD). NEJM. 2019;381:1227–1239. PMID 31553835.
  3. Stempel DA, Raphiou IH, Kral KM, et al. Serious asthma events with fluticasone plus salmeterol versus fluticasone alone (AUSTRI). NEJM. 2016;374:1822–1830.
  4. U.S. Food and Drug Administration. Advair Diskus label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021077s055lbl.pdf

Medical disclaimer

This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients — it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.

Read our editorial standards for how we source, review, and update these pages.